RxDoctor Payments Data

Hartwell Rainey, PA

Physician Assistant · Midlothian, VANPI 1730780461

Payments from drug & device makers

$2,961in general payments, 2019–2025

Across 190 payments — averaging $15.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$816
  • Novo Nordisk$435
  • Amgen$334
  • Lilly USA, LLC$244
  • Pfizer$200
  • Boehringer Ingelheim$120
  • plus $813 from 23 others

What the payments were for

  • Food & beverage$2,94299%
  • Education$201%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,961 in reported general payments places this provider in the 85th percentile of 3,376 physician assistant providers in Virginia.

See all physician assistant providers in Virginia

Medicare billing

Part B allowed, 2024
$42,700
Medicare patients
238
Services billed
588

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin18$26,209
EliquisApixaban20$23,810
OzempicSemaglutide15$20,374
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog11$11,850
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog12$5,782
Novolin 70-30 FlexpenInsulin Nph Hum/Reg Insulin Hm14$1,430
Atorvastatin Calcium146$843
Ezetimibe15$640
Rosuvastatin Calcium69$616
Losartan Potassium58$607
Simvastatin52$567
Tamsulosin Hcl53$552
Lisinopril77$549
Albuterol Sulfate HfaAlbuterol Sulfate15$541
Metoprolol Succinate65$504

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$120$26,20918 claims
PfizerEliquis$200$23,81020 claims
Novo NordiskOzempic$435$20,37415 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,376 physician assistant providers in Virginia.

Other physician assistant in Midlothian

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →